X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.businesswire.com/news/home/20221116005292/en/Noveome-Biotherapeutics-Inc.-Announces-New-Appointments-to-Board-of-Directors
https://www.trialsitenews.com/a/noveome-biotherapeutics-receives-rare-pediatric-disease-designation-and-orphan-drug-designation-for-necrotizing-enterocolitis-in-neonates-013a48e8
https://www.prnewswire.com/news-releases/noveome-biotherapeutics-inc-commences-phase-1-clinical-study-of-st266-application-for-infectious-disease-including-covid-19-301318438.html
https://www.businesswire.com/news/home/20210607005051/en/Noveome-Biotherapeutics-Inc.-Announces-Preliminary-Results-of-its-Phase-1-Open-Label-Clinical-Trial-Evaluating-Intranasal-Delivery-of-Lead-Candidate-ST266-In-Glaucoma-Suspect-Patients
https://www.businesswire.com/news/home/20210524005017/en/Noveome-Biotherapeutics-Inc.-Announces-Christopher-J.-P.-Velis-as-Chief-Executive-Officer
https://www.businesswire.com/news/home/20210201005135/en/Noveome-Biotherapeutics-Inc.-and-Walter-Reed-Army-Institute-of-Research-to-Study-Noveome%E2%80%99s-Lead-Product-Candidate-ST266-in-Traumatic-Brain-Injury
Market Place
Share 
